SAN CARLOS, Calif. & LISBON, Portugal--March 7, 2024--CuraSen Therapeutics, Inc., a clinical-stage company developing small molecule therapies to treat neurodegenerative disease, announced that it will present additional positive Phase 2a...
FDA Approves Plexxikon Drug
News | 10. 18. 2011
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.